| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 1,038,614 | 1,615,013 | 1,483,895 | | Cost of Revenue | 209,480 | 214,508 | 227,099 | | | Gross Profit | 829,134 | 1,400,505 | 1,256,796 | | | Operating Expenses | | Research Development | 457,913 | 663,029 | 460,064 | | Selling General and Administrative | 510,441 | 407,148 | 548,896 | | Non Recurring | 1,411,316 | (7,008) | 103 | | Others | 22,732 | 19,421 | 23,141 | | | | Total Operating Expenses | 2,402,402 | 1,082,590 | 1,032,204 | | | | Operating Income or Loss | (1,573,268) | 317,915 | 224,592 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,898) | 58,530 | 29,634 | | Earnings Before Interest And Taxes | (1,590,111) | 376,445 | 254,226 | | Interest Expense | 11,614 | 12,374 | 12,348 | | Income Before Tax | (1,601,725) | 364,071 | 241,878 | | Income Tax Expense | 252,313 | 67,819 | 99,704 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,854,038) | 296,252 | 142,174 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 418 | | Other Items |
-
|
-
|
-
| | | | Net Income | (1,854,038) | 296,252 | 142,592 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,854,038) | $296,252 | $142,592 |
|
0.29% Nasdaq 
Income Statement
